Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
创新神经技术进步中心 (CINTA) - 外展核心
基本信息
- 批准号:10707293
- 负责人:
- 金额:$ 21.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAreaCaregiversCollaborationsCommunicationCommunitiesDevelopmentDiagnosisEducationElectronic MailEvaluationFaceFocus GroupsFundingIncubatorsIndustryInterdisciplinary StudyLeadershipLearningMentorsMethodsNeeds AssessmentOutcomePatientsPerformancePress ReleasesProcessProfessional OrganizationsPublicationsResearchRiskServicesSpecific qualifier valueTechnologyTrainingTranslational ResearchUnited States National Institutes of HealthVoicecommercializationequity, diversity, and inclusionexperienceinnovationinterestmeetingsnervous system disordernewsoutreachprogramsresearch data disseminationsocial mediasuccesstoolweb site
项目摘要
Abstract - OUTREACH CORE
The Outreach Core will be the public face and communications center for CINTA. Under the direction of the
CINTA Coordination Team and the Steering Committee, and with logistical support from the Administrative
Core, the Outreach Core is responsible for broad outreach to a diverse community of stakeholders using a
variety of methods including needs assessments, solicitation announcements, news and education, research
dissemination, and collaboration with the other funded hubs. Capturing and amplifying the voices of patients,
caregivers, and diverse, underrepresented communities will be a central guiding principle. CIMIT has decades
of experience in translational research and multidisciplinary collaboration. Since its founding in 1998, CIMIT
has supported nearly 800 innovative projects, including annual needs assessments, issuance of solicitations,
customized innovator support, and targeted dissemination of relevant information. The proposed CINTA
Outreach Core will build upon the experience and lessons learned from supporting these NIH programs and
will add further process innovations. CINTA will conduct annual needs assessments and stakeholder outreach
to support the areas of interests of the NIH Participating Organizations. Strategies for conducting annual needs
assessments will be based on input from the Steering Committee and Consumer Advisory Board. These
panels have been constituted to broadly reflect the areas of emphasis of the NIH Participating Organizations.
CINTA will use methods that CIMIT has employed in past years and will also broadly engage stakeholders by
use of social media and Zoom focus groups for identifying unmet needs for disorders of the nervous system.
These sessions will include the perspectives of patient advocates, nonprofit and philanthropic organizations,
professional societies, the academic research community, industry, payers, and others. Results of annual
needs assessments will be presented to CINTA leadership to develop appropriate criteria for performance
specifications where technology-based solutions would have the highest impact to address identified unmet
needs. Specifications will be included in the solicitation and will be used as review criteria by the Evaluation
Core. The Outreach Core will augment efforts by Mentor Teams, consultants, and subject matter experts to
train funded teams, including conducting an “Investor Forum” to connect subproject teams with potential
investors. CINTA will collaborate with other hubs to plan annual meetings and publications for sharing
outcomes and lessons learned. CINTA will facilitate communications among funded hubs and internal
dissemination of outcomes and lessons learned. If desired, CINTA will be pleased to construct and maintain a
Blueprint MedTech: Incubator Hubs program-specific website to be shared among the other hubs. Creating a
public narrative for both the Blueprint MedTech: Incubator Hubs program and for awardees is critical to
success. Press releases for program launch can be developed and disseminated through email, social media,
and, optionally, via a press wire service or press list.
摘要-外展核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN C. SCHACHTER其他文献
STEVEN C. SCHACHTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN C. SCHACHTER', 18)}}的其他基金
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
创新神经技术进步中心 (CINTA) - 评估核心
- 批准号:
10707297 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
创新神经技术进步中心 (CINTA) - 行政核心
- 批准号:
10516345 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
创新神经技术进步中心 (CINTA) - 行政核心
- 批准号:
10707291 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
创新神经技术进步中心 (CINTA) - 外展核心
- 批准号:
10516346 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
创新神经技术进步中心 (CINTA) - 评估核心
- 批准号:
10516347 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
FEASIBILITY OF A COMBINED SEIZURE DETECTOR-VNS SYSTEM
结合癫痫检测器-VNS 系统的可行性
- 批准号:
7718938 - 财政年份:2008
- 资助金额:
$ 21.15万 - 项目类别:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
ADAD ON 534U87 治疗部分性癫痫发作的评估
- 批准号:
6118949 - 财政年份:1998
- 资助金额:
$ 21.15万 - 项目类别:
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
洛西加蒙作为治疗复杂性部分性癫痫发作的单一疗法
- 批准号:
6265420 - 财政年份:1998
- 资助金额:
$ 21.15万 - 项目类别:
TRIAL OF GP47779 (NHD OF OXCARBAZEPINE) ADMINISTERED IV TO INPATIENTS
GP47779(奥卡西平 NHD)对住院患者静脉注射的试验
- 批准号:
6265423 - 财政年份:1998
- 资助金额:
$ 21.15万 - 项目类别:
EXTENSION TRIAL OF OXCARBAZEPINE IN PATIENTS W/ PARTIAL SEIZURES
奥卡西平在部分癫痫发作患者中的扩展试验
- 批准号:
6265424 - 财政年份:1998
- 资助金额:
$ 21.15万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 21.15万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 21.15万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 21.15万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 21.15万 - 项目类别:














{{item.name}}会员




